A worldwide group drove by University of British Columbia analyst Dr. Josef Penninger has discovered a preliminary medication that adequately obstructs the cell entryway SARS-CoV-2 uses to infects its hosts. The discoveries, distributed today in Cell, hold guarantee as a treatment equipped for halting early disease of the novel coronavirus that, as of April 2,…